Advances in Migraine Treatment



Topic: Internal medicine.

Destination: Projects that will be considered for support will focus on increasing the understanding of healthcare professionals on the management and care of people with migraine. Pfizer is interested in educational initiatives that encompass the following:

  • Unmet need and disease burden associated with migraine.
  • The role of CGRP in the pathophysiology of migraine.
  • Anti-CGRP therapies for acute and prophylactic treatment of migraine.

Budget: Up to $250,000/project.

Duration: Up to 2 years.

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: